Antibody Radionuclide Conjugates Market to Reach USD 15 Billion by 2035 at 10.6% CAGR
Antibody Radionuclide Conjugates Market Overview The Antibody Radionuclide Conjugates Market is gaining significant traction as targeted cancer therapies and precision oncology continue to advance. Antibody radionuclide conjugates combine the tumor-targeting specificity of antibodies with the therapeutic effect of radioactive isotopes, …